Different distribution of c-myc and MIB-1 positive cells in malignant meningiomas with reference to TGFs, PDGF, and PgR expression.
We investigated the expression of transforming growth factors (TGFs), platelet-derived growth factor (PDGF), progesterone receptor (PgR), and c-myc in 20 cases of meningioma of various grades: 17 benign, 2 atypical, and 1 anaplastic. All cases of atypical and anaplastic meningioma were positive for c-myc, whereas all 17 benign meningiomas were negative for c-myc immunostaining. Expression of TGF-alpha, TGF-beta, and PDGF-BB proteins was seen in more than 80% of the meningioma cases and was not restricted to their histological grade of meningioma. PgR was expressed mainly in benign meningiomas. Moreover, the cells expressing c-myc protein were not usually stained by MIB-1. These results indicate that c-myc does not directly work on the proliferation of meningioma cells, and even in homogeneous meningioma cells, there may be many functional variations that lead the meningioma cells to their growth.
Nagashima
G
G
Department of Neurosurgery, Showa University, Fujigaoka Hospital, Kanagawa, Japan.
Asai
J
J
Suzuki
R
R
Fujimoto
T
T
D000368:Aged; D000911:Antibodies, Monoclonal; D005260:Female; D006801:Humans; D007150:Immunohistochemistry / Q000379:methods; D019394:Ki-67 Antigen / Q000378:metabolism*; D008297:Male; D008577:Meningeal Neoplasms / Q000378:metabolism* / Q000473:pathology; D008579:Meningioma / Q000378:metabolism* / Q000473:pathology; D008875:Middle Aged; D010982:Platelet-Derived Growth Factor / Q000378:metabolism*; D016271:Proto-Oncogene Proteins c-myc / Q000378:metabolism*; D011980:Receptors, Progesterone / Q000378:metabolism*; D014018:Tissue Distribution; D015291:Transforming Growth Factors / Q000378:metabolism*
D000911:Antibodies, Monoclonal; D019394:Ki-67 Antigen; D010982:Platelet-Derived Growth Factor; D016271:Proto-Oncogene Proteins c-myc; D011980:Receptors, Progesterone; D015291:Transforming Growth Factors